Researchers Develop Treatment for 'Incurable' Brain Tumors
Purdue University is developing a groundbreaking approach to treating "incurable" glioblastoma brain tumors.
Source: counselheal.com
Sandro Matosevic News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sandro Matosevic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sandro Matosevic Today - Breaking & Trending Today
_cell_identifies_cancer_cell_-_Illustration_-_Alpha_Tauri_3D_Graphics_M1_df26c964f0144a8b912d9638f99be561-620x480.jpg)
Monon Bioventures receives SBIR grant to develop glioblastoma therapeutic created at Purdue
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
Source: news-medical.net
Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
Source: purdue.edu
Registration open for 17th annual Garnet E. Peck Symposium
The 17th Annual Garnet E. Peck Symposium will be held April 7 by the Department of Industrial and Physical Pharmacy with corporate support from Aprecia, Catalent Biologics and MED Institute. The symposium will be held on the second floor of Stewart Center.
Source: purdue.edu